InnovAge Quarterly Cash Flow Statement
NASDAQ: INNVHealth CareMedical/Nursing ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
InnovAge free cash flow
In the quarter ended Jun 30, 2026, InnovAge generated $21.3 million of operating cash flow and spent $4.3 million on capital expenditures. That left free cash flow of $17.0 million, a free-cash-flow margin of 6.5% of revenue. Free cash flow was up 85.4% from the prior year's $9.2 million.
Summary generated from market data by MetaCap's automated system. Methodology
InnovAge cash flow statement (quarterly)
| Quarter (USD) | Q4 20262026-06-30 | Q3 20262026-03-31 | Q2 20262025-12-31 | Q1 20262025-09-30 | Q4 20252025-06-30 | Q3 20252025-03-31 | Q2 20252024-12-31 | Q1 20252024-09-30 | Q4 20242024-06-30 | Q3 20242024-03-31 | Q2 20242023-12-31 | Q1 20242023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 9.78M | -29.94M | 11.80M | 7.67M | -5.01M | -11.13M | -13.49M | -5.71M | -2.25M | -6.18M | -3.82M | -10.96M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 6.36M | 4.82M | 4.88M | 5.08M | 3.39M | 5.39M | 5.32M | 5.41M | 5.33M | 5.06M | 4.29M | 4.27M |
| Stock-Based Compensation | 1.73M | 1.79M | 1.22M | 2.31M | 1.55M | 2.03M | 1.87M | 2.16M | 1.69M | 1.55M | 1.77M | 1.82M |
| Change in Working Capital | 909.00K | 40.00M | 1.10M | -12.41M | 10.63M | 25.51M | 3.55M | -12.09M | -11.84M | 2.84M | -19.27M | -29.51M |
| Operating Cash Flow | 21.29M | 18.14M | 21.36M | 3.92M | 9.00M | 24.63M | 6.75M | -7.52M | 1.87M | 3.51M | -9.29M | -32.98M |
| Capital Expenditures | -4.27M | -3.60M | -2.36M | -4.08M | 179.00K | -2.90M | -1.34M | -2.20M | -3.31M | -452.00K | -1.59M | -2.57M |
| Investing Cash Flow | -4.82M | -3.80M | -2.90M | -814.00K | 976.00K | -8.14M | 4.40M | -2.79M | 934.00K | -1.05M | -23.11M | -3.14M |
| Debt Issued | 0 | 0 | 0 | 60.08M | 0 | 0 | 0 | 0 | — | — | — | — |
| Debt Repaid | -10.00M | -634.00K | -634.00K | -60.01M | -951.00K | -950.00K | -949.00K | -949.00K | -949.00K | -949.00K | -949.00K | -948.00K |
| Financing Cash Flow | -14.11M | -2.01M | -2.40M | -11.00K | -5.25M | -2.12M | -4.09M | -7.62M | 44.00K | -2.44M | -1.91M | -2.73M |
| Net Change in Cash | 2.35M | 12.33M | 16.06M | 3.02M | 3.67M | 14.38M | 7.06M | -17.93M | 2.85M | 13.00K | -34.32M | -38.85M |
| Free Cash Flow | 17.02M | 14.54M | 19.00M | -153.00K | 9.18M | 21.73M | 5.41M | -9.72M | -1.43M | 3.06M | -10.88M | -35.56M |
This table shows 12 quarterly periods of InnovAge's cash flow statement, from Q4 2026 back to Q1 2024, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow INNV's reporting calendar. What is a cash flow statement?